Sublingual Versus Oral Misoprostol for induction of labour at term
Phase 1
- Conditions
- Health Condition 1: null- Term Pregnancy
- Registration Number
- CTRI/2016/07/007116
- Lead Sponsor
- Kasturba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Live singleton pregnancy at a gestational age of 37 weeks or more with medical or obstetric indication for induction.
Cephalic presentation
Unfavourable cervix (Bishopâ??s score <= 6 )
Reassuring fetal heart tracing
Exclusion Criteria
Cephalopelvic disproportion.
Previous caesarean section or history of uterine surgery.
Multiple gestations.
Malpresentation.
Known hypersensitivity reactions to the use of prostaglandins
Known contraindications to the use of prostaglandins (eg. Asthma)
Parity > 4
Significant maternal or fetal concerns requiring induction under continuous monitoring
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of women delivering vaginally within 24 hours.Timepoint: December 2014 to November 2016
- Secondary Outcome Measures
Name Time Method The time interval from induction to vaginal delivery. <br/ ><br>No. of misoprostol doses required. <br/ ><br>No. of patients requiring oxytocin augmentation <br/ ><br>No. of failed inductions. <br/ ><br>No. of Caesarean section <br/ ><br> No. of Uterine hyperstimulation <br/ ><br>Neonatal outcomes <br/ ><br>Gastrointestinal side effects and pyrexia <br/ ><br>Timepoint: December 2014 to November 2016